Sonoma Pharmaceuticals, Inc. announced on November 21, 2024, the relaunch of its prescription dermatology and eye care product lines in the United States. This move signals a renewed focus on these key domestic markets.
The relaunched prescription-strength products include Acuicyn® Eyelid & Eyelash Hygiene, Epicyn® Facial Cleanser, Levicyn® Dermal Spray, Levicyn® Gel, Levicyn® Spray Gel, and Celacyn® Scar Management Gel.
This strategic relaunch aims to re-energize sales and market penetration in the higher-margin U.S. prescription segment, leveraging Sonoma's proprietary Microcyn technology.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.